Fundraising Fox

Bugworks Research

Wilmington, US · Founded 2014 · Delaware corporation · 1 known investors

bugworksresearch.com ↗

Founders & leadership

Bugworks Research was founded in 2014 by Anand Anandkumar.

AA
Anand AnandkumarFounder

Investors · 1

3one4 CapitalGift City, Gandhinagar, Gujarat · $364K – $30M

Reported raises · per SEC filings

Form D private placements

$39.1M disclosed across 5 rounds · 2015–2024

▶$6.8MraisedMar 2024 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pradeep FernandesExecutive Officer
  • Santanu DattaDirector
  • Anand AnandkumarExecutive Officer, Director
  • Tejasvi RaviDirector
  • Atsushi UsamiDirector
  • Venkataraman SubramanianDirector
Offering amount
$15.8M
Amount sold
$6.8M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16MraisedDec 2021 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bala SubramanianExecutive Officer, Director
  • Pradeep FernandesExecutive Officer
  • Santanu DattaExecutive Officer, Director
  • Atsushi UsamiDirector
  • Anand AnandkumarExecutive Officer, Director
  • Tejasvi RaviDirector
Offering amount
$19.4M
Amount sold
$16M
First sale
Nov 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.2MraisedNov 2020 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Anand AnandkumarExecutive Officer, Director
  • Santanu DattaExecutive Officer, Director
  • Pradeep FernandesExecutive Officer
  • Bala SubramanianExecutive Officer, Director
  • Atsushi UsamiDirector
Offering amount
$6.2M
Amount sold
$6.2M
Minimum investment
$250K
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.5MraisedAug 2018 · 13 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Atushi UsamiDirector
  • Anand AnandkumarExecutive Officer, Director
  • Pradeep FernandesExecutive Officer
  • Bala SubramanianDirector
  • Santanu DattaDirector
Offering amount
$9.2M
Amount sold
$8.5M
Minimum investment
$95.8K
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedNov 2015 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anand AnandkumarExecutive Officer
Offering amount
$2.3M
Amount sold
$1.6M
Minimum investment
$26.5K
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Zymeworks3 shared keywordsZymeworks is a royalty-driven biotechnology company that develops multifunctional antibody-based therapeutics, including antibody-drug conjugates and multispecific antibodies, for solid tumors and other difficult-to-treat diseases. It manages a portfolio of licensed healthcare assets — including the approved drug Ziihera (zanidatamab) and pasritamig — and partners its therapeutic platforms with biopharmaceutical companies to generate royalty and milestone revenue.

Companies competing with Bugworks Research for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

Who founded Bugworks Research?
Bugworks Research was founded by Anand Anandkumar in 2014.
Who are Bugworks Research's investors?
Bugworks Research's investors include 3one4 Capital.
How much funding has Bugworks Research raised?
Bugworks Research has disclosed $39.1M raised across 5 rounds.
Where is Bugworks Research headquartered?
Bugworks Research is headquartered in Wilmington, US.